Export 660 results:
Hornick, R. B., I M. S., R W., A C. R., P L. J., Snyder M. J., et al. (1971).  The Broad Street Pump Revisited: Response of Volunteers to Ingested Cholera Vibrios. Bulletin New York Academy of Medicine. 47(10), 
Rendtorff, R.. C. (1954).  The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. American journal of hygiene. 59, 2.
Hay, RJ., & Johns NE. (2014).  The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions.
Reed, HR. (2004).  The Inactivation of Microbes by Sunlight : Solar Disinfection as a Water Treatment Process.
DuPont, H.. L., Chappell C.. L., Sterling C.. R., Okhuysen P.. C., Rose J.. B., & Jakubowski W.. (1995).  The infectivity of Cryptosporidium parvum in healthy volunteers. The New England journal of medicine. 332, 13.
Gale, P. (2006).  The infectivity of transmissible spongiform encephalopathy agent at low doses: the importance of phospholipid. Journal of applied microbiology. 101, 261–274.
Couch, R.. B., Knight V.., Jr R.. G. Douglas, Black S.. H., & Hamory B.. H. (1969).  The minimal infectious dose of adenovirus type 4; the case for natural transmission by viral aerosol.. Transactions of the American Clinical and Climatological Association. 80, 205.
Gurian, PL., & Rose JB. (2013).  Theory and Practice of Quantitative Microbial Risk Assessment: An Introduction.
Jacobson, RH. (1994).  Three-dimensional structure of β-galactosidase from E. coli.
Rogers, J.. V., Choi Y.. W., Giannunzio L.. F., Sabourin P.. J., Bornman D.. M., Blosser E.. G., et al. (2007).  Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92. Microbial Pathogenesis. 43, 2.
Cornick, N.. A., & Helgerson A.. F. (2004).  Transmission and Infectious Dose of Escherichia coli O157:H7 in Swine. Applied and Environmental Microbiology. 70, 9.
Cornick, NA., & Helgerson AF. (2004).  Transmission and infectious dose of Escherichia coli O157:H7 in swine.
Goldman, D.. A. (2000).  Transmission of viral respiratory infections in the home. The Pediatric Infectious Disease Journal. 19, 97-102.
Organization, W. Health (2010).  Treatment of tuberculosis guidelines.
Benin, A. L., Benson R. F., & Besser R. E. (2012).  Trends in Legionnaires Disease, 1980-1998: Declining Mortality and New Patterns of Diagnosis. Clinical Infectious Diseases. 35, 1039-1046.
Tärnvik, A.., & Berglund L.. (2003).  Tularaemia. European Respiratory Journal. 21, 2.
Ellis, J.., Oyston P.. C. F., Green M.., & Titball R.. W. (2002).  Tularemia. Clinical Microbiology Reviews. 15, 4.
Saslaw, S.., Eigelsbach H.. T., Wilson H.. E., Prior J.. A., & Carhart S.. (1961).  Tularemia vaccine study I: intracutaneous challenge. Arch Intern Med. 107, 121-133.
Saslaw, S.., Eigelsbach H.. T., Prior J.. A., Wilson H.. E., & Carhart S.. (1961).  Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med. 702-714.
Stuart, BM. (1945).  Tularemic pneumonia: Review of American literature and report of 15 additional cases.. American Journal of the Medical Sciences. 210,
Fan, S.., Deng G.., Song J.., Tian G.., Suo Y.., Jiang Y.., et al. (2009).  Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology.. 384, 1.
Bieber, D.., Ramer S.. W., C-y W., Murray W.. J., Tobe T.., Fernandez R.., et al. (1998).  Type IV Pili, Transient Bacterial Aggregates, and Virulence of Enteropathogenic Escherichia coli. Science.. 280, 5372.
Bieber, D.., & (1998).  Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science. 280, 2114-2118.
Schell, M.. A., Ulrich R.. L., Ribot W.. J., Brueggemann E.. E., Hines H.. B., Chen D.., et al. (2007).  Type VI secretion is a major virulence determinant in Burkholderia mallei. Molecular Microbiology. 64, 6.
Hornick, R.. B., Greisman S.. E., Woodward T.. E., DuPont H.. L., Dawkins A.. T., & Snyder M.. J. (1970).  Typhoid fever: pathogenesis and immunologic control. The New England journal of medicine. 283, 13.